Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial

[1]  Lakshmi Rajagopal,et al.  A recombinant alpha-like protein subunit vaccine (GBS-NN) provides protection in murine models of Group B Streptococcus infection. , 2022, The Journal of infectious diseases.

[2]  A. Pawłowski,et al.  A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains , 2022, Cell reports. Medicine.

[3]  A. Pawłowski,et al.  Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women. , 2021, Vaccine.

[4]  B. Kampmann,et al.  Maternal Immunization: Nature Meets Nurture , 2020, Frontiers in Microbiology.

[5]  F. O’Halloran,et al.  A review of antibiotic resistance in Group B Streptococcus: the story so far , 2020, Critical reviews in microbiology.

[6]  P. Heath,et al.  A Vaccine Against Group B Streptococcus: Recent Advances , 2020, Infection and drug resistance.

[7]  S. Schrag,et al.  Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Madhi,et al.  Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Madhi,et al.  Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Madhi,et al.  Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Madhi,et al.  Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  I. Margarit,et al.  The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Madhi,et al.  Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[14]  S. Madhi,et al.  Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. , 2016, The Lancet. Infectious diseases.

[15]  G. Leroux-Roels,et al.  A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women. , 2016, Vaccine.

[16]  R. Devlieger,et al.  Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.

[17]  S. Madhi,et al.  Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants , 2015, Expert review of vaccines.

[18]  B. Lepenies,et al.  Carbohydrate-Based Vaccines: An Overview. , 2015, Methods in molecular biology.

[19]  J. Afset,et al.  Survey of Immunological Features of the Alpha-Like Proteins of Streptococcus agalactiae , 2014, Clinical and Vaccine Immunology.

[20]  田村 大輔,et al.  Centers for Disease Control and Prevention(CDC)での生活 , 2013 .

[21]  C. Baker,et al.  Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  M. B. Bacchi Reggiani,et al.  Group B Streptococcus Late-Onset Disease: 2003–2010 , 2013, Pediatrics.

[23]  M. Carneiro-Sampaio,et al.  IgG Placental Transfer in Healthy and Pathological Pregnancies , 2011, Clinical & developmental immunology.

[24]  G. Berbers,et al.  Transplacental Transport of IgG Antibodies Specific for Pertussis, Diphtheria, Tetanus, Haemophilus influenzae Type b, and Neisseria meningitidis Serogroup C Is Lower in Preterm Compared With Term Infants , 2010, The Pediatric infectious disease journal.

[25]  E. Johnsson,et al.  Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine. , 2007, Cell host & microbe.

[26]  L. Madoff,et al.  The group B streptococcal alpha C protein binds alpha1beta1-integrin through a novel KTD motif that promotes internalization of GBS within human epithelial cells. , 2007, Microbiology.

[27]  L. Madoff,et al.  Alpha C Protein of Group B Streptococcus Binds Host Cell Surface Glycosaminoglycan and Enters Cells by an Actin-dependent Mechanism* , 2004, Journal of Biological Chemistry.

[28]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[29]  L. Madoff,et al.  The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells , 2002, Cellular microbiology.

[30]  D. Kasper,et al.  Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. , 2000, The Journal of infectious diseases.

[31]  D. Kasper,et al.  Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. , 1999, The Journal of infectious diseases.

[32]  D. Kasper,et al.  Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1996, The Journal of clinical investigation.

[33]  S. Quataert,et al.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S , 1995, Clinical and diagnostic laboratory immunology.

[34]  R. Sager,et al.  Maternal—Fetal Transport of Immunoglobulin G and Its Subclasses During the Third Trimester of Human Pregnancy , 1994, American journal of reproductive immunology.

[35]  J. Boslego,et al.  A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. , 1981, JIM - Journal of Immunological Methods.

[36]  D. Kasper,et al.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.